We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
2021
A Swiss company, Vifor, prides itself on "helping patients lead better, healthier lives" and also specializes in iron deficie…
The annual tradition continues in Marburg, Germany, where CSL Behring’s presence is expanding.
Kenia Rincon, CSL Behring’s Chief Information Security Officer, recently led a conversation on colorism for the Healthcare Bu…
As we close out the year, we asked 16 patient organization leaders, patients and employees to reflect on the last 12 months.
Australian government donates millions of Oxford-AstraZeneca COVID-19 vaccines manufactured by CSL to neighboring nations, in…
Medical researchers continue to unravel the mysteries of pain and look for new ways to help patients manage it.
Cancelling plans is especially hard at holiday time. Get advice from experts on how to manage a chronic condition at the most…
Still holiday shopping? We recommend books and other stocking stuffers that help spread the word about rare diseases.
The virus that causes COVID-19 mainly spreads in the air, so antibacterial wipes and other deep-cleaning methods for surfaces…
Popular search terms:
Americas
Asia Pacific
Middle East
Europe
.jpg?h=900&w=1600&cropregion=0,0,1600,900&hash=24E4528F9367509DC7D78904778DF7A9)
